Recently, ZIP4 has been shown to be expressed in multiple tumours, particularly pancreatic cancer [65], hepatocellular carcinoma (HCC) [66], and non-small-cell lung cancer (NSCLC) [67]. Here, SLC39A4 is linked to neoplasm.